Cell & Genome Engineering Core

The general aim of the Cell and Genome Engineering Core is to provide stable genetic modification of kidney cells using CRISPR/Cas9 and transposon vectors for the nephrology community. It will also facilitate research efforts by isolating specific cell types from mouse and human kidneys for protein/RNA analysis and cell culture.

Core Assays and Service

Core Leadership

Matthew Wilson, MD, PhD

Professor of Medicine, Division of Nephrology & Hypertension

Email

Roy Zent, MD, PhD

Professor of Medicine, Division of Nephrology & Hypertension
Vice Chair for Research, Department of Medicine

Email

Please contact Core leadership for pricing.

For more information and questions, please email Karen Thompson, Program Manager, or call (615) 343-5400.